Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-3n8w4pcCompleted
Open-label, single-arm trial of lidocaine in bruxism and temporomandibular disorder (TMD), sponsored by Pontifícia Universidade Católica de São Paulo. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-3n8w4pc.